Device Surgical Care

Ostene

Payments companies reported to CMS as associated with Ostene. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$21Kassociated payments (2023-2025)

228clinicians with associated payments

1company reporting

By year

2023 $5,778

2024 $3,187

2025 $12K

Payments reported as associated with Ostene, per program year, as reported to CMS.

Who makes it

Baxter Healthcare $21K associated with Ostene (2023-2025)

Specialties most often involved

Neurological Surgery $8,164

Thoracic Surgery (Cardiothoracic Vascular Surgery) $2,951

Surgical $2,842

Physician Assistant $1,712

Surgery $1,502

Medical $475

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Ostene

These are the largest totals companies reported as associated with Ostene. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Camilo Molina	Saint Louis, MO	Neurological Surgery	$7,198.94
Alice Cherqui	Jonesboro, AR	Surgery	$374.13
Stephen Palmer	Rochester, NY	Medical	$234.64
Daniel Verdine	Rochester, NY	Surgical	$234.64
Pouya Hemmati	Little Rock, AR	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$217.96
Emily Briceland	Rochester, NY	Physician Assistant	$217.36
Chelsea Norcross	Rochester, NY	Surgical	$217.36
Lauren Matla	Norwalk, CT	Surgical	$217.35
Melanie Proud	Rochester, NY	Surgical	$217.35
Anne Mitchko	Rochester, NY	Surgical	$217.35

Prescribed Ostene?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.